The 2022-2027 Outlook for Clocks in Japan

This study covers the latent demand outlook for clocks across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of i...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Watches in Japan

This study covers the latent demand outlook for watches across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of ...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Surfing in Japan

This study covers the latent demand outlook for surfing across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of ...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Cold-Chain Generic Drugs in Japan

This study covers the latent demand outlook for cold-chain generic drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent shar...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Hearing Aid Devices in Japan

This study covers the latent demand outlook for hearing aid devices across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for HIV and AIDS Therapeutics in Japan

This study covers the latent demand outlook for HIV and AIDS therapeutics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent sha...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Epilepsy Treatments in Japan

This study covers the latent demand outlook for epilepsy treatments across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Insulin Delivery Devices in Japan

This study covers the latent demand outlook for insulin delivery devices across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent shar...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Facial Aesthetics in Japan

This study covers the latent demand outlook for facial aesthetics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the c...

11/4/2021 | Japan Outlook 2022

The 2022-2027 Outlook for Ventilators in Japan

This study covers the latent demand outlook for ventilators across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is...

11/4/2021 | Japan Outlook 2022

This study covers the latent demand outlook for clocks across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for clocks. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of clocks as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Apple, Google, Garmin, Citizen Holdings, The Swatch Group, and Timex. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for watches across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for watches. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of watches as including all commonly understood products falling within this broad category, such as luxury watches, smart watches, vintage watches, luxury-smartwatches, and water resistant watches, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Apple, Google, Garmin, Citizen Holdings, The Swatch Group, and Timex. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for surfing across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for surfing. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of surfing as including all commonly understood products and/or services falling within this broad category, such as surf parks and pools, surfwear, and surf-gear artificial wave technology and surfing lessons, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Billabong, Quiksilver, Curl, Adidas, Volcom, and Nike. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for cold-chain generic drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for cold-chain generic drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of cold-chain generic drugs as including all commonly understood products falling within this broad category, such as vaccines, monoclonal antibodies, and generic drugs, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Sanofi Pasteur, GlaxoSmithKline, Novartis, AstraZeneca, Intrexon, and Abbott Laboratories. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for hearing aid devices across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for hearing aid devices. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of hearing aid devices as including all commonly understood products falling within this broad category, such as miniature behind-the-ear (BTE), in-the-canal (ITC), and completely-in-the-canal (CIC) devices, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Hansaton, WIDEX Corporation, Starkey, Resound, Oticon, and Unitron. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for HIV and AIDS therapeutics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for HIV and AIDS therapeutics. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of HIV and AIDS therapeutics as including all commonly understood products falling within this broad category, such as multi-class fixed dose combination tablets treatments that boost the immune system, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Gilead Sciences, GlaxoSmithKline, BMS, Abbott Laboratories, Merck, and Johnson & Johnson. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for epilepsy treatments across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for epilepsy treatments. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of epilepsy treatments as including all commonly understood products and/or services falling within this broad category, such as antiepileptic drugs (AED) and gamma aminobutyric acid modulators and ion channel blockers, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Pfizer, Johnson & Johnson, UCB Pharma, Abbott Laboratories, GlaxoSmithKline, and Novartis. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for insulin delivery devices across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for insulin delivery devices. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of insulin delivery devices as including all commonly understood products falling within this broad category, such as insulin pumps, syringes, and pens artificial pancreas devices and traditional insulin pump accessories, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Medtronic, F. Hoffmann-La Roche, Abbott Laboratories, Novo Nordisk, Eli Lilly and Company, and Sanofi. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for facial aesthetics across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for facial aesthetics. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of facial aesthetics as including all commonly understood products falling within this broad category, such as medication and procedures for cosmetic purposes, such as scars, wrinkles, moles, blemishes pertaining to the face, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include ZELTIQ, MiraDry, NeoGraft, Sientra, Merz, and Galderma. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

This study covers the latent demand outlook for ventilators across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for ventilators. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of ventilators as including all commonly understood products falling within this broad category, such as ventilators for chronic obstructive pulmonary disease (COPD), intensive care unit (ICU) beds equipped with ventilators technologies that prevent lung injury multimodal ventilators respiratory therapy non-invasive ventilation and technologies that aid in reducing the risk of lung injury from high inspiratory pressure, are more customized to patients with varying levels of complications, promote speaking ability, and improve patient comfort during mechanical ventilation, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Smiths Medical, Anda Medical, Coast Medical, Foremost Equipment, Med-Equip Locators, and Newport Medical Instruments. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2021). ...

11/4/2021

LATEST REPORTS

PRESS RELEASES

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT